The FDA inspection reviewed QT Imaging’s Quality Management System (QMS) and related processes that support the Company’s operations, with no Form 483 observations issued. The inspector also provided positive feedback regarding the organization of QT Imaging’s QMS and the Company’s responsiveness throughout the inspection process.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.